Latest News

Angiotensin receptor blockers could improve response to cancer immunotherapy

A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.

Source link

Related posts

Incorporating conductive textiles into clothing could connect many wearable devices


Prevalence of anti-protein C antibodies and acquired activated protein C resistance and in systemic lupus erythematosus


Opinion: Hey, doctors: Don’t be no-shows (again) on Election Day


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy